Oric Pharmaceuticals
Price & Volume
Stats
See more52W Range | $6.33-$15.59 |
Market Cap | $568.2M |
Shares Short | 12M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.83 |
News
See moreYahoo Finance • 2 days ago
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 12 days ago
ORIC® Pharmaceuticals Announces Focused Registrational Clinical Development Plans for Lead Programs, Extended Cash Runway, and Updated Corporate Milestones
Yahoo Finance • 19 days ago
ORIC® Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Updates
Yahoo Finance • last month
ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
About
CEO | Dr. Jacob M. Chacko M.B.A., M.D. |
Address | 240 East Grand Avenue, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 115 |
